No valuation for Theranos is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised and the funding record below are the closest available signals.
- ·Watch Theranos: the Monday email on marks, rounds and moves
Theranos funding history
No funding rounds for Theranos are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
How much has Theranos raised?
Theranos has filed 2 Form Ds with the SEC since 2010, most recently in May 2017 ($582 million sold to 34 investors).
How Theranos's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Theranos, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →